Financial Performance - The company's operating revenue for 2022 was 3.45 billion RMB, a decrease of 8% compared to the previous year[5]. - The net profit attributable to shareholders, after deducting non-recurring gains and losses, was -419 million RMB, a decline of 18.96% year-on-year, with losses increasing by 67 million RMB compared to the previous year[5]. - The company's operating revenue for 2022 was ¥3,450,620,276.09, a decrease of 8.00% compared to ¥3,750,514,066.26 in 2021[25]. - The net profit attributable to shareholders was -¥374,816,820.15, representing a decline of 61.25% from -¥232,438,571.77 in the previous year[25]. - The cash flow from operating activities improved significantly, with a net cash flow of -¥11,995,832.70, an increase of 96.72% compared to -¥366,149,530.54 in 2021[25]. - The basic and diluted earnings per share were both -¥0.8400, down 61.54% from -¥0.5200 in 2021[25]. - The net assets attributable to shareholders decreased by 8.15% to ¥3,228,756,373.83 from ¥3,515,301,302.78 in 2021[25]. - The company has faced uncertainty regarding its ability to continue as a going concern, as indicated by the negative net profits over the last three years[25]. Contracts and Revenue Sources - The total amount of new contracts signed by the company was approximately 4.6 billion RMB, an increase of about 12.2% year-on-year, with the subsidiary Puyutech contributing approximately 2.12 billion RMB, a growth of 58.2%[5]. - The main business revenue was CNY 3.32 billion, accounting for 96.35% of total revenue, with a year-on-year decrease of 8.28%[83]. - The revenue from instruments and related software was CNY 2.35 billion, representing 68.18% of total revenue, with a year-on-year increase of 12.76%[83]. - Domestic revenue was CNY 3.35 billion, down 9.39% year-on-year, while international revenue increased by 92.31% to CNY 99 million[81]. Research and Development - The company plans to increase R&D investment and market promotion for new products, leading to an increase in financial expenses due to rising interest-bearing debt[5]. - The company has invested a total of 3 billion RMB in R&D, maintaining a high proportion of investment to accelerate technology platform accumulation[79]. - The total R&D investment for 2022 was approximately ¥566.33 million, representing 16.41% of the operating revenue, an increase from 13.95% in 2021[93]. - The number of R&D personnel increased by 16.07% to 1,726 in 2022, accounting for 24.54% of the total workforce[93]. - The company is advancing multiple R&D projects, including a clinical protein analysis system and a digital fluorescence immunoassay system, both of which are in the market promotion phase[92]. Product Development and Innovation - The company is focused on the development of high-end analytical instruments, which are crucial for scientific research and technological innovation[36]. - The company has developed a series of new monitoring devices for environmental applications, including photochemical and greenhouse gas monitoring systems[40]. - The company has launched a new online monitoring system for emerging water pollutants, utilizing triple quadrupole mass spectrometry technology[43]. - The company has established a comprehensive carbon monitoring solution, integrating monitoring, data analysis, and simulation processes[44]. - The company has launched multiple innovative products in the high-end scientific instrument sector, achieving substantial sales growth and maintaining a leading position in technology and market[63]. Financial Management and Governance - The company does not plan to distribute cash dividends, issue bonus shares, or increase share capital from reserves[7]. - The company has established a transparent performance evaluation and incentive mechanism for senior management, adhering to legal standards[126]. - The company maintains independence from its controlling shareholders in business, assets, personnel, and finance[128]. - The company has implemented a comprehensive salary and performance assessment system for its management team[139]. - The company emphasizes legal operation and integrity in tax payment, focusing on creating economic value while fulfilling social responsibilities[165]. Risks and Challenges - The company faces various risks including technology, market, accounts receivable, expansion, mergers and acquisitions, human resources, and PPP project risks[6]. - The company is addressing accounts receivable risks, as a significant portion of its total assets is tied up in receivables from government and large industrial clients[114]. - The company is enhancing its internal audit and control systems to mitigate management and operational risks associated with rapid expansion[116]. - The company is cautiously pursuing new mergers and acquisitions, having established a specialized acquisition team and an initial integration management system[117]. Market Position and Strategy - The global analytical instrument market is experiencing stable growth, with China’s market share increasing rapidly despite being relatively small[109]. - The company aims to enhance its competitiveness in the analytical instrument sector by integrating production, learning, research, and application, focusing on core technology platforms[111]. - The company plans to develop a series of innovative products tailored to high-end, diverse, and customized analytical detection needs[112]. - The company is committed to accelerating the domestic research and development and localization process of high-end analytical instruments[111]. Corporate Social Responsibility - The company respects and protects the rights of stakeholders, promoting mutual benefits with suppliers and customers[127]. - The company adheres to labor laws to protect employee rights and interests, fostering a harmonious labor relationship[166]. - The company has committed to not engaging in any competitive business or product development that may conflict with its own operations[170].

编号：2015-002 证券代码：300203 证券简称：聚光科技 聚光科技（杭州）股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|----------------------------|----------------------------------------------------------| | | | | | 投资者关系活动 | □ | 特定对象调研 □分析师会议 | | 类别 | □ | 媒体采访 □业绩说明会 | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | □一对一沟通 | | | ■ | 其他（深交所联合深圳证监局在公司举办"践行中国梦·走 | | | 近上市公司" 投资者开放日） | | | 参与单位名称及 | 1 | 、通过上海证券、中信证券、财通证券、广发证券、西南证券、 | | 人员姓名 | | 东方证券、东北证券、中银国际、财达证券、中信建投、国信证 | | | 券、国元证券等报名的近 | 60 名中小投资者； | | | | 2、深交所信息公司、证券时报、第一财经电视、第一财经新闻 | ...

证券代码：300203 证券简称：聚光科技 编号：2016-001 聚光科技（杭州）股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|-------------------------|--------------------------------------------------------| | | | | | 投资者关系活动 | □ | 特定对象调研 □分析师会议 | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | □一对一沟通 | | | ■ | 其他（深圳证券交易所联合高盛 -2016 深圳上市公司企业 | | | 日） | | | 参与单位名称及 | | 安联投资、汇丰环球投资管理（香港）有限公司、纽宾凯集团 | | 人员姓名 | | 有限公司、华夏基金（香港）有限公司、法国巴黎投资管理亚 | | | 洲有限公司、 | indus capital advisors(HK) ltd. 、 OLD PEAK | | | LIMITED | 、景顺投资管理有限公司、 V ...

证券代码：300203 证券简称：聚光科技 编号：2016-003 聚光科技（杭州）股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | |----------------|----------------|-------|------------------------------------| | | | | | | 投资者关系活动 | □ 特定对象调研 | | □ 分析师会议 | | 类别 | □ 媒体采访 | | □ 业绩说明会 | | | □ 新闻发布会 | | □ 路演活动 | | | □ 现场参观 | | □ 一对一沟通 | | | ■ | | 其他 （投资者接待日活动） | | 参与单位名称及 | | | 侏罗纪资产 伏少松 上海高毅 周 龙 | | 人员姓名 | | | 华夏未来 褚 天 浙江重阳 曾平庞 | | | | | 中财招商 吴 羽 毕盛投资 林建军 | | | | | 众心投资 王 瑩 中财招商 刘福杰 | | | | | 中财招商 金天裕 浙农控股 许 磊 | | | | | 拓聚投资 伍丹妮 天安财产保险 杨 雪 | | | | | 海通证券 ...

证券代码：300203 证券简称：聚光科技 聚光科技（杭州）股份有限公司投资者关系活动记录表 编号：2016-002 | --- | --- | --- | --- | --- | |----------------|-----------------------------|---------|---------------------------|-------------------------------------| | | | | | | | 投资者关系活动 | □ 特定对象调研 | | □ | 分析师会议 | | 类别 | □ 媒体采访 | | □ | 业绩说明会 | | | □ 新闻发布会 | | □ | 路演活动 | | | □ 现场参观 | | | □ 一对一沟通 | | | ■ | | 其他 （投资者接待日活动） | | | 参与单位名称及 | | | | 元大证券 严泽文 浙江天堂硅谷 尤宣竣 | | 人员姓名 | | | | 东吴证券 翟堃 上海盟洋投资 吴有钦 | | | | | | 银万资本 翟庚元 上海汇利资产 朱远峰 | | | | | | 财富证券 邹建军 宝新能源投资 闫 ...

编号：2017-003 证券代码：300203 证券简称：聚光科技 聚光科技（杭州）股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|----------------------------------|--------------------------------------------| | | | | | 投资者关系活动 | ■ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 一对一沟通 | | | □ 其他 | | | 参与单位名称及 | | 东海证券 隋 欣 浙江瑞特资产 王忆宁 | | 人员姓名 | | 坤易投资 林捷鸣 东方资产管理 吴思雨 | | | | 英大证券 孙 超 景林资产管理 徐 宽 | | | | 五矿资本 郭 慧 上海汇利资产 朱远峰 | | | | 罗夏资本 高溪健 北京宏道投资 范 凯 | | | | 工银瑞信 钟 睿 张 青 东方证券 王楷迪 陈 晨 | | | 华泰证券 徐 科 王玮嘉 张雪蓉 ...

证券代码：300203 证券简称：聚光科技 编号：2017-002 聚光科技（杭州）股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|--------------------------------|---------------------------------------| | | | | | 投资者关系活动 | □ 特定对象调研 | □ 分析师会议 | | 类别 | □ 媒体采访 | 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 一对一沟通 | | | ■ 其他 （投资者接待日活动） | | | 参与单位名称及 | | 君煦投资 张 文 季诚冠 国泰君安 杜丽丹 | | 人员姓名 | 东来方元 姜 垚 物产公用 揭建强 | | | | 广发证券 许 洁 中信建投 朱瀚清 | | | | | 君合投资 陆 诚 张英顺 国信证券 王 宁 | | | | 中国平安 庞文亮 银领资本 陈秋东 | | | | 开域投资 白培根 红塔证券 俞海海 | | | | 浙银资本 毛眉琪 德意志银行 王斐丽 | | ...

Group 1: Company Overview - The company focuses on high-end analytical instruments, with a complex business model involving multiple technology platforms and product lines applied across various industries such as environmental monitoring and industrial production [4][5]. - Since its establishment, the company has invested nearly 2 billion in R&D, mastering various technology platforms including mass spectrometry, spectroscopy, and chromatography, making it a leader in the domestic analytical instrument sector [5][6]. Group 2: Market Position and Competition - The company aims to differentiate itself through customized and application-specific products, prioritizing online and portable instruments to replace imported products in various sectors [7][8]. - Compared to international competitors, the company faces challenges due to the late start of the domestic industry and the scarcity of excellent technical talent, leading to a focus on self-developed product lines [6][9]. Group 3: Future Growth and Opportunities - The demand for environmental monitoring instruments is expected to remain high due to increasing governmental emphasis on environmental protection, with significant growth anticipated over the next five years [8][9]. - The company plans to expand into new fields such as semiconductor applications, leveraging market opportunities presented by the construction of numerous wafer and reagent factories in China [7][9]. Group 4: Talent Acquisition and Development - The company faces challenges in attracting skilled management, sales, and technical personnel due to the human capital-intensive nature of the industry [9]. - To address talent shortages, the company focuses on self-training for R&D personnel and plans to establish overseas R&D centers to recruit and retain more talent [9][10].